Status: Recruiting
Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine
The main goal of this trial is to evaluate the safety and immunogenicity of the candidate N. gonorrhoeae vaccine, LTB-NG6.
Participants needed: 142
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: LimmaTech Biologics AGUpdated: Aug 11, 2026Locations: 1
Eligibility criteria
Aged 18-50 years (inclusive) at the time of the first injection [+5]
Health conditions that, in the opinion of the Investigator, may interfere with o... [+20]